TY - JOUR AU - Colmegna, I. AU - Ohata, B. R. AU - Menard, H. A. PY - 2012 DA - 2012// TI - Current understanding of rheumatoid arthritis therapy JO - Clin Pharmacol Ther. VL - 91 UR - https://doi.org/10.1038/clpt.2011.325 DO - 10.1038/clpt.2011.325 ID - Colmegna2012 ER - TY - BOOK AU - Silman, A. J. H. M. PY - 2001 DA - 2001// TI - Epidemiology of the rheumatic diseases PB - Oxford University Press CY - New York ID - Silman2001 ER - TY - JOUR AU - Smolen, J. S. AU - Aletaha, D. AU - Bijlsma, J. W. AU - Breedveld, F. C. AU - Boumpas, D. AU - Burmester, G. PY - 2010 DA - 2010// TI - Treating rheumatoid arthritis to target: recommendations of an international task force JO - Ann Rheum Dis. VL - 69 UR - https://doi.org/10.1136/ard.2009.123919 DO - 10.1136/ard.2009.123919 ID - Smolen2010 ER - TY - JOUR AU - Smolen, J. S. AU - Landewe, R. AU - Breedveld, F. C. AU - Dougados, M. AU - Emery, P. AU - Gaujoux-Viala, C. PY - 2010 DA - 2010// TI - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs JO - Ann Rheum Dis. VL - 69 UR - https://doi.org/10.1136/ard.2009.126532 DO - 10.1136/ard.2009.126532 ID - Smolen2010 ER - TY - JOUR AU - Choy, E. PY - 2012 DA - 2012// TI - Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis JO - Rheumatology (Oxford). VL - 51 UR - https://doi.org/10.1093/rheumatology/kes113 DO - 10.1093/rheumatology/kes113 ID - Choy2012 ER - TY - JOUR AU - Dennis, G. AU - Holweg, C. T. AU - Kummerfeld, S. K. AU - Choy, D. F. AU - Setiadi, A. F. AU - Hackney, J. A. PY - 2014 DA - 2014// TI - Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics JO - Arthritis Res Ther. VL - 16 UR - https://doi.org/10.1186/ar4555 DO - 10.1186/ar4555 ID - Dennis2014 ER - TY - JOUR AU - Smolen, J. S. AU - Schoels, M. M. AU - Nishimoto, N. AU - Breedveld, F. C. AU - Burmester, G. R. AU - Dougados, M. PY - 2013 DA - 2013// TI - Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions JO - Ann Rheum Dis. VL - 72 UR - https://doi.org/10.1136/annrheumdis-2012-202469 DO - 10.1136/annrheumdis-2012-202469 ID - Smolen2013 ER - TY - JOUR AU - Yoshida, Y. AU - Tanaka, T. PY - 2014 DA - 2014// TI - Interleukin 6 and rheumatoid arthritis JO - Biomed Res Int. VL - 2014 UR - https://doi.org/10.1155/2014/698313 DO - 10.1155/2014/698313 ID - Yoshida2014 ER - TY - JOUR AU - Hashizume, M. AU - Mihara, M. PY - 2011 DA - 2011// TI - The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis JO - Arthritis. VL - 2011 UR - https://doi.org/10.1155/2011/765624 DO - 10.1155/2011/765624 ID - Hashizume2011 ER - TY - JOUR AU - Scheller, J. AU - Chalaris, A. AU - Schmidt-Arras, D. AU - Rose-John, S. PY - 2011 DA - 2011// TI - The pro- and anti-inflammatory properties of the cytokine interleukin-6 JO - Biochim Biophys Acta. VL - 1813 UR - https://doi.org/10.1016/j.bbamcr.2011.01.034 DO - 10.1016/j.bbamcr.2011.01.034 ID - Scheller2011 ER - TY - JOUR AU - Ferraccioli, G. AU - Bracci-Laudiero, L. AU - Alivernini, S. AU - Gremese, E. AU - Tolusso, B. AU - Benedetti, F. PY - 2010 DA - 2010// TI - Interleukin-1beta and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis JO - Mol Med. VL - 16 UR - https://doi.org/10.2119/molmed.2010.00067 DO - 10.2119/molmed.2010.00067 ID - Ferraccioli2010 ER - TY - JOUR AU - Mimata, Y. AU - Kamataki, A. AU - Oikawa, S. AU - Murakami, K. AU - Uzuki, M. AU - Shimamura, T. PY - 2012 DA - 2012// TI - Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis JO - Int J Rheum Dis. VL - 15 UR - https://doi.org/10.1111/j.1756-185X.2011.01656.x DO - 10.1111/j.1756-185X.2011.01656.x ID - Mimata2012 ER - TY - JOUR AU - Uchiyama, Y. AU - Yorozu, K. AU - Hashizume, M. AU - Moriya, Y. AU - Mihara, M. PY - 2008 DA - 2008// TI - Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis JO - Biol Pharm Bull. VL - 31 UR - https://doi.org/10.1248/bpb.31.1159 DO - 10.1248/bpb.31.1159 ID - Uchiyama2008 ER - TY - JOUR AU - Hassanzadeh-Ghassabeh, G. AU - Devoogdt, N. AU - Pauw, P. AU - Vincke, C. AU - Muyldermans, S. PY - 2013 DA - 2013// TI - Nanobodies and their potential applications JO - Nanomedicine (Lond). VL - 8 UR - https://doi.org/10.2217/nnm.13.86 DO - 10.2217/nnm.13.86 ID - Hassanzadeh-Ghassabeh2013 ER - TY - JOUR AU - Unciti-Broceta, J. D. AU - Castillo, T. AU - Soriano, M. AU - Magez, S. AU - Garcia-Salcedo, J. A. PY - 2013 DA - 2013// TI - Novel therapy based on camelid nanobodies JO - Ther Deliv. VL - 4 UR - https://doi.org/10.4155/tde.13.87 DO - 10.4155/tde.13.87 ID - Unciti-Broceta2013 ER - TY - JOUR AU - Muyldermans, S. PY - 2013 DA - 2013// TI - Nanobodies: natural single-domain antibodies JO - Annu Rev Biochem. VL - 82 UR - https://doi.org/10.1146/annurev-biochem-063011-092449 DO - 10.1146/annurev-biochem-063011-092449 ID - Muyldermans2013 ER - TY - JOUR AU - Bakker, N. P. AU - Erck, M. G. AU - Otting, N. AU - Lardy, N. M. AU - Noort, R. C. AU - ‘t Hart, B. A. PY - 1992 DA - 1992// TI - Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region JO - J Exp Med. VL - 175 UR - https://doi.org/10.1084/jem.175.4.933 DO - 10.1084/jem.175.4.933 ID - Bakker1992 ER - TY - JOUR AU - Otting, N. AU - Heijmans, C. M. AU - Noort, R. C. AU - Groot, N. G. AU - Doxiadis, G. G. AU - Rood, J. J. PY - 2005 DA - 2005// TI - Unparalleled complexity of the MHC class I region in rhesus macaques JO - Proc Natl Acad Sci U S A. VL - 102 UR - https://doi.org/10.1073/pnas.0409084102 DO - 10.1073/pnas.0409084102 ID - Otting2005 ER - TY - JOUR AU - Woo, J. AU - Vierboom, M. P. AU - Kwon, H. AU - Chao, D. AU - Ye, S. AU - Li, J. PY - 2013 DA - 2013// TI - PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis JO - Arthritis Res Ther. VL - 15 UR - https://doi.org/10.1186/ar4400 DO - 10.1186/ar4400 ID - Woo2013 ER - TY - JOUR AU - Mihara, M. AU - Kotoh, M. AU - Nishimoto, N. AU - Oda, Y. AU - Kumagai, E. AU - Takagi, N. PY - 2001 DA - 2001// TI - Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys JO - Clin Immunol. VL - 98 UR - https://doi.org/10.1006/clim.2000.4989 DO - 10.1006/clim.2000.4989 ID - Mihara2001 ER - TY - JOUR AU - Hart, B. A. AU - Bank, R. A. AU - Roos, J. A. AU - Brok, H. AU - Jonker, M. AU - Theuns, H. M. PY - 1998 DA - 1998// TI - Collagen-induced arthritis in rhesus monkeys: evaluation of markers for inflammation and joint degradation JO - Br J Rheumatol. VL - 37 UR - https://doi.org/10.1093/rheumatology/37.3.314 DO - 10.1093/rheumatology/37.3.314 ID - Hart1998 ER - TY - JOUR AU - Vierboom, M. P. AU - Jonker, M. AU - Bontrop, R. E. AU - ‘t Hart, B. PY - 2005 DA - 2005// TI - Modeling human arthritic diseases in nonhuman primates JO - Arthritis Res Ther. VL - 7 UR - https://doi.org/10.1186/ar1773 DO - 10.1186/ar1773 ID - Vierboom2005 ER - TY - JOUR AU - Vierboom, M. P. AU - Jonker, M. AU - Tak, P. P. AU - ‘t Hart, B. A. PY - 2007 DA - 2007// TI - Preclinical models of arthritic disease in non-human primates JO - Drug Discov Today. VL - 12 UR - https://doi.org/10.1016/j.drudis.2007.02.012 DO - 10.1016/j.drudis.2007.02.012 ID - Vierboom2007 ER - TY - JOUR AU - Putnam, F. W. AU - Liu, Y. S. AU - Low, T. L. PY - 1979 DA - 1979// TI - Primary structure of a human IgA1 immunoglobulin. IV. Streptococcal IgA1 protease, digestion, Fab and Fc fragments, and the complete amino acid sequence of the alpha 1 heavy chain JO - J Biol Chem VL - 254 ID - Putnam1979 ER - TY - JOUR AU - Lobo, E. D. AU - Hansen, R. J. AU - Balthasar, J. P. PY - 2004 DA - 2004// TI - Antibody pharmacokinetics and pharmacodynamics JO - J Pharm Sci. VL - 93 UR - https://doi.org/10.1002/jps.20178 DO - 10.1002/jps.20178 ID - Lobo2004 ER - TY - JOUR AU - Vierboom, M. AU - Breedveld, E. AU - Kondova, I. AU - ‘t Hart, B. A. PY - 2008 DA - 2008// TI - The significance of non-human primates as preclinical models of human arthritic disease JO - Expert Opin Drug Discov VL - 3 UR - https://doi.org/10.1517/17460441.3.3.299 DO - 10.1517/17460441.3.3.299 ID - Vierboom2008 ER - TY - STD TI - Holz JB, Sargentini-Maier L, De Bruyn S, Gachályi B, Udvaros I, Rojkovich B, et al. Twenty-four weeks of treatment with a novel anti-IL-6 receptor Nanobody® (ALX-0061) resulted in 84 % ACR20 improvement and 58 % DAS28 remission in a phase I/II study in RA. Ann Rheum Dis. 2013;72:A64. ID - ref27 ER - TY - JOUR AU - Owyang, A. M. AU - Issafras, H. AU - Corbin, J. AU - Ahluwalia, K. AU - Larsen, P. AU - Pongo, E. PY - 2011 DA - 2011// TI - XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1beta-mediated diseases JO - MAbs. VL - 3 UR - https://doi.org/10.4161/mabs.3.1.13989 DO - 10.4161/mabs.3.1.13989 ID - Owyang2011 ER - TY - JOUR AU - Rathanaswami, P. AU - Roalstad, S. AU - Roskos, L. AU - Su, Q. J. AU - Lackie, S. AU - Babcook, J. PY - 2005 DA - 2005// TI - Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8 JO - Biochem Biophys Res Commun. VL - 334 UR - https://doi.org/10.1016/j.bbrc.2005.07.002 DO - 10.1016/j.bbrc.2005.07.002 ID - Rathanaswami2005 ER - TY - JOUR AU - Zunszain, P. A. AU - Ghuman, J. AU - Komatsu, T. AU - Tsuchida, E. AU - Curry, S. PY - 2003 DA - 2003// TI - Crystal structural analysis of human serum albumin complexed with hemin and fatty acid JO - BMC Struct Biol. VL - 3 UR - https://doi.org/10.1186/1472-6807-3-6 DO - 10.1186/1472-6807-3-6 ID - Zunszain2003 ER - TY - JOUR AU - Kuo, T. T. AU - Baker, K. AU - Yoshida, M. AU - Qiao, S. W. AU - Aveson, V. G. AU - Lencer, W. I. PY - 2010 DA - 2010// TI - Neonatal Fc receptor: from immunity to therapeutics JO - J Clin Immunol. VL - 30 UR - https://doi.org/10.1007/s10875-010-9468-4 DO - 10.1007/s10875-010-9468-4 ID - Kuo2010 ER - TY - JOUR AU - Clark, R. AU - Olson, K. AU - Fuh, G. AU - Marian, M. AU - Mortensen, D. AU - Teshima, G. PY - 1996 DA - 1996// TI - Long-acting growth hormones produced by conjugation with polyethylene glycol JO - J Biol Chem. VL - 271 UR - https://doi.org/10.1074/jbc.271.36.21969 DO - 10.1074/jbc.271.36.21969 ID - Clark1996 ER - TY - JOUR AU - Venkatachalam, M. A. AU - Rennke, H. G. PY - 1978 DA - 1978// TI - The structural and molecular basis of glomerular filtration JO - Circ Res. VL - 43 UR - https://doi.org/10.1161/01.RES.43.3.337 DO - 10.1161/01.RES.43.3.337 ID - Venkatachalam1978 ER - TY - JOUR AU - Davies, B. AU - Morris, T. PY - 1993 DA - 1993// TI - Physiological parameters in laboratory animals and humans JO - Pharm Res. VL - 10 UR - https://doi.org/10.1023/A:1018943613122 DO - 10.1023/A:1018943613122 ID - Davies1993 ER - TY - JOUR AU - Nguyen, A. AU - Reyes, A. E. AU - Zhang, M. AU - McDonald, P. AU - Wong, W. L. AU - Damico, L. A. PY - 2006 DA - 2006// TI - The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin JO - Protein Eng Des Sel. VL - 19 UR - https://doi.org/10.1093/protein/gzl011 DO - 10.1093/protein/gzl011 ID - Nguyen2006 ER - TY - JOUR AU - Frey, N. AU - Grange, S. AU - Woodworth, T. PY - 2010 DA - 2010// TI - Population pharmacokinetic analysis of tocilizumab in patients with rheumatoid arthritis JO - J Clin Pharmacol. VL - 50 UR - https://doi.org/10.1177/0091270009350623 DO - 10.1177/0091270009350623 ID - Frey2010 ER - TY - JOUR AU - Shinkura, H. AU - Imazeki, I. AU - Yamazaki, M. AU - Oda, Y. AU - Kotoh, M. AU - Mihara, M. PY - 1998 DA - 1998// TI - In vivo blocking effects of a humanized antibody to human interleukin-6 receptor on interleukin-6 function in primates JO - Anticancer Res. VL - 18 ID - Shinkura1998 ER - TY - JOUR AU - Arnett, F. C. AU - Edworthy, S. M. AU - Bloch, D. A. AU - McShane, D. J. AU - Fries, J. F. AU - Cooper, N. S. PY - 1988 DA - 1988// TI - The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis JO - Arthritis Rheum. VL - 31 UR - https://doi.org/10.1002/art.1780310302 DO - 10.1002/art.1780310302 ID - Arnett1988 ER - TY - JOUR AU - Brok, H. P. AU - Tekoppele, J. M. AU - Hakimi, J. AU - Kerwin, J. A. AU - Nijenhuis, E. M. AU - Groot, C. W. PY - 2001 DA - 2001// TI - Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys JO - Clin Exp Immunol. VL - 124 UR - https://doi.org/10.1046/j.1365-2249.2001.01487.x DO - 10.1046/j.1365-2249.2001.01487.x ID - Brok2001 ER - TY - JOUR AU - Hakimi, J. AU - Chizzonite, R. AU - Luke, D. R. AU - Familletti, P. C. AU - Bailon, P. AU - Kondas, J. A. PY - 1991 DA - 1991// TI - Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys JO - J Immunol. VL - 147 ID - Hakimi1991 ER - TY - STD TI - Vierboom M, Breedveld E, Hart B, Coulon F, Vanhove B. Evaluation of selective manipulation of the CD28 co-stimulation pathway in the rhesus monkey model of collagen-induced arthritis (2013). https://ww2.rheumatology.org/apps/MyAnnualMeeting/Abstract/36556. Accessed 3 June 2015. UR - https://ww2.rheumatology.org/apps/MyAnnualMeeting/Abstract/36556 ID - ref41 ER - TY - JOUR AU - Shimozuru, Y. AU - Yamane, S. AU - Fujimoto, K. AU - Terao, K. AU - Honjo, S. AU - Nagai, Y. PY - 1998 DA - 1998// TI - Collagen-induced arthritis in nonhuman primates: multiple epitopes of type II collagen can induce autoimmune-mediated arthritis in outbred cynomolgus monkeys JO - Arthritis Rheum. VL - 41 UR - https://doi.org/3.0.CO;2-S DO - 3.0.CO;2-S ID - Shimozuru1998 ER - TY - JOUR AU - Terato, K. AU - Arai, H. AU - Shimozuru, Y. AU - Fukuda, T. AU - Tanaka, H. AU - Watanabe, H. PY - 1989 DA - 1989// TI - Sex-linked differences in susceptibility of cynomolgus monkeys to type II collagen-induced arthritis. Evidence that epitope-specific immune suppression is involved in the regulation of type II collagen autoantibody formation JO - Arthritis Rheum VL - 32 UR - https://doi.org/10.1002/anr.1780320613 DO - 10.1002/anr.1780320613 ID - Terato1989 ER - TY - JOUR AU - Emery, P. AU - Gabay, C. AU - Kraan, M. AU - Gomez-Reino, J. PY - 2007 DA - 2007// TI - Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis JO - Rheumatol Int. VL - 27 UR - https://doi.org/10.1007/s00296-007-0357-y DO - 10.1007/s00296-007-0357-y ID - Emery2007 ER - TY - JOUR AU - Heinrich, P. C. AU - Castell, J. V. AU - Andus, T. PY - 1990 DA - 1990// TI - Interleukin-6 and the acute phase response JO - Biochem J. VL - 265 ID - Heinrich1990 ER - TY - JOUR AU - Genovese, M. C. AU - McKay, J. D. AU - Nasonov, E. L. AU - Mysler, E. F. AU - Silva, N. A. AU - Alecock, E. PY - 2008 DA - 2008// TI - Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study JO - Arthritis Rheum. VL - 58 UR - https://doi.org/10.1002/art.23940 DO - 10.1002/art.23940 ID - Genovese2008 ER - TY - JOUR AU - Maini, R. N. AU - Taylor, P. C. AU - Szechinski, J. AU - Pavelka, K. AU - Broll, J. AU - Balint, G. PY - 2006 DA - 2006// TI - Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate JO - Arthritis Rheum. VL - 54 UR - https://doi.org/10.1002/art.22033 DO - 10.1002/art.22033 ID - Maini2006 ER - TY - JOUR AU - Nishimoto, N. AU - Terao, K. AU - Mima, T. AU - Nakahara, H. AU - Takagi, N. AU - Kakehi, T. PY - 2008 DA - 2008// TI - Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease JO - Blood. VL - 112 UR - https://doi.org/10.1182/blood-2008-05-155846 DO - 10.1182/blood-2008-05-155846 ID - Nishimoto2008 ER -